Leukocyte adhesion deficiency (LAD) represents a group of rare, genetically determined immunodeficiency disorders that impair the ability of white blood cells to adhere to vascular endothelium, ...
Zacks Investment Research on MSN
RCKT Stock Up as FDA Accepts Resubmitted BLA for Gene Therapy
Rocket Pharmaceuticals RCKT announced that the FDA has accepted the resubmitted biologics license application (BLA) seeking ...
The β 2 common integrin subunit CD18 is essential for leukocyte–endothelial adhesion and extravasation to inflamed or infected tissue. Damaging variants in ITGB2 ...
CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage, clinical biotechnology company advancing an integrated and sustainable pipeline of genetic therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback